Champions Oncology provides an end-to-end range of research and development solutions to deliver greater certainty in the fight against cancer. Our deep expertise includes screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived xenograft (PDX) models, and modeling treatment response in the clinic. Champions Oncology is your partner in meeting today?s needs and innovating for tomorrow?s challenges. Mission:?Through scientific excellence, we focus on meeting the challenges of cancer drug development by providing innovative solutions that ultimately improve patients? lives.
51 to 200
TypeCompany - Public (CSBR)
Revenue$10 to $25 million (USD) per year
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2007